摘要
Although induction of ferroptosis and inhibition of transforming growth factor-beta (TGF-beta) signaling are both effective ways to reform the tumor microenvironment (TME) and render low-immunogenic tumors responsive to immune checkpoint inhibitor therapy, dose-limiting side effects remain major obstacles hindering their clinical application. Herein, novel sorafenib and anti-TGF-beta antibody loaded Fe3O4/Gd2O3 hybrid nanoparticles with conjugation of arginine-glycine-aspartic dimer (FeGd-HN@Sorafenib@TGF-beta-antibody@RGD2, FG-STR) are developed. Sorafenib significantly enhances FeGd-HN-triggered ferroptosis and improves maturation and phagocytosis of dendritic cells (DCs) by inducing damage-associated molecular patterns released from ferroptotic cancer cells, while the anti-TGF-beta antibody further synergizes with enhanced ferroptosis to promote DC maturation and the recruitment of CD8(+) T cells, thus heating the TME. Moreover, the incorporation of RGD2 facilitates the uptake of the FG-STR in tumor cells which lead to a significant dosage reduction of both sorafenib and anti-TGF-beta antibody to avoid dose-limiting toxicities. Finally, in vitro and in vivo experiments show that FG-STR has significantly superior intrinsic magnetic resonance imaging (MRI) capability than that of Gadovist, effectively inhibits tumor growth and lung metastasis, and increases the efficacy of anti-programmed cell death-1 treatment. Taken together, this study provides a promising strategy for new advanced MRI-guided TME heating therapies.
学科与关键词
- A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapyGuo, Shuai; Xiong, Wei; Zhu, Jiaoyang; Feng, Jie; Zhou, Ruilong; Fan, Qingdeng; Zhang, Qianqian; Li, Zongheng; Yang, Jing; Zhou, Huimin; Yi, Peiwei; Feng, Yanqiu; Yang, Sugeun; Qiu, Xiaozhong; Xu, Yikai; Shen, Zheyu*Biomaterials, 2023, 302: 122300.被引 5
- Cycloacceleration of Reactive Oxygen Species Generation Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for Tumor Ferroptosis TherapyZhou, Huimin; Lu, Xuanyi; Du, Chao; Zhou, Zijian*; Feng, Jie; Liang, Zhiyu; Xu, Yikai*; Qiu, Xiaozhong*; Shen, Zheyu*Small, 2022, 18(35): 2202705.被引 16
- A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment RemodelingHuang, Lin; Feng, Jie*; Zhu, Jiaoyang; Yang, Jing; Xiong, Wei; Lu, Xuanyi; Chen, Sijin; Yang, Sugeun; Li, Yan; Xu, Yikai*; Shen, Zheyu*Advanced Healthcare Materials, 2023, 12(18): 2203362.被引 15
